Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Liver Disease”

Showing 20 of 0 results

Not applicableStudy completedNCT05100485
What this trial is testing

Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)

Who this might be right for
Compensated Advanced Chronic Liver Disease
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000
Post-approval studies (Phase 4)UnknownNCT05467826
What this trial is testing

Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis

Who this might be right for
Hepatitis CCirrhosis
Peking University People's Hospital 100
Early research (Phase 1)Looking for participantsNCT04874428
What this trial is testing

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Insel Gruppe AG, University Hospital Bern 24
Large-scale testing (Phase 3)Study completedNCT04112303
What this trial is testing

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 37
Testing effectiveness (Phase 2)Ended earlyNCT05161481
What this trial is testing

Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Hypertension, Portal
Boehringer Ingelheim 80
Large-scale testing (Phase 3)Looking for participantsNCT07701993
What this trial is testing

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
GlaxoSmithKline 1,740
Testing effectiveness (Phase 2)Study completedNCT00043303
What this trial is testing

Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis

Who this might be right for
Liver FibrosisCirrhosis
InterMune 502
Early research (Phase 1)Study completedNCT00781976
What this trial is testing

Antiviral Activity of AZD7295 in HCV Carriers

Who this might be right for
Hepatitis C
Arrow Therapeutics 31
Large-scale testing (Phase 3)UnknownNCT00437476
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 60
Testing effectiveness (Phase 2)Study completedNCT03449446
What this trial is testing

Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 395
Not applicableUnknownNCT04281303
What this trial is testing

Endoscopic Bariatric Therapy in NASH Cirrhosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Instituto de Investigación Marqués de Valdecilla 10
Testing effectiveness (Phase 2)Study completedNCT02243280
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 174
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Large-scale testing (Phase 3)Looking for participantsNCT06051617
What this trial is testing

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Who this might be right for
Primary Biliary Cholangitis
Gilead Sciences 402
Testing effectiveness (Phase 2)Study completedNCT02993250
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 33
Post-approval studies (Phase 4)Study completedNCT02224456
What this trial is testing

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 197
Not applicableUnknownNCT04975477
What this trial is testing

CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102)

Who this might be right for
Compensated Advanced Chronic Liver Disease
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000
Not applicableStudy completedNCT03246048
What this trial is testing

Long Term Follow-up of Hepatitis C Cured Patients

Who this might be right for
Chronic Hepatitis CChronic Liver DiseaseCirrhosis
Hospital Universitari Vall d'Hebron Research Institute 300
Not applicableStudy completedNCT04307264
What this trial is testing

CHESS Criteria for Varices Screening in Compensated Advanced Chronic Liver Disease (CHESS2001/APPHA2001)

Who this might be right for
Compensated Advanced Chronic Liver DiseaseVarices Needing Treatment
Hepatopancreatobiliary Surgery Institute of Gansu Province 2,000
Large-scale testing (Phase 3)Study completedNCT01500616
What this trial is testing

Telaprevir Open-Label Study in Co-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen-Cilag International NV 122
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation